Abstract
Objectives Cochlear synaptopathy, a type of cochlear deafferentation that occurs with aging and following loud noise exposure, is expected to be common in humans and to have negative impacts on auditory perception. However, there is currently no means for diagnosing cochlear deafferentation in living humans. Auditory brainstem response (ABR) wave I amplitude and the envelope following response (EFR) are auditory evoked potentials that have been proposed as potential non-invasive indicators of cochlear deafferentation. However, these measures may be impacted by outer hair cell (OHC) dysfunction, making them difficult to interpret. One potential method for estimating the degree of deafferentation in individual patients is to combine evoked potential and distortion product otoacoustic emission (DPOAE) measurements with a computational model of the auditory periphery (CMAP). The goal of this study was to evaluate the ability of auditory evoked potentials, with and without the CMAP, to predict risk factors for cochlear synaptopathy (age and history of military noise exposure).
Design In a population of military Veterans and non-Veterans with up to a mild sensorineural hearing loss, a CMAP was used with Bayesian regression to predict synapse numbers across cochlear frequency (synaptograms) for individual human participants based on their ABR, EFR, and/or DPOAE measurements. Linear regression models were then used to evaluate the ability of the synaptograms and various ABR wave I amplitude, EFR magnitude, and DPOAE measurements to predict age and Veteran status. All Veterans were assumed to have at least some history of military noise exposure.
Results High frequency (4 and 5.6 kHz) ABR wave I amplitude measurements and synaptograms generated from high frequency ABR wave I amplitudes performed the best at predicting participant age. Accounting for OHC function (as indicated by DPOAEs) in the generation of the synaptograms or by including DPOAEs in the linear regression models had limited impact on the ability of ABR wave I amplitudes to predict age. DPOAEs were highly predictive of Veteran status, making it difficult to isolate the ability of the auditory evoked potentials to predict Veteran status.
Conclusions High frequency ABR wave I amplitudes and synaptograms generated from high frequency ABR wave I amplitudes were able to predict participant age within approximately 6 years, with or without incorporating DPOAE measurements. This suggests that high frequency ABR wave I amplitude measurements are good candidates for non-invasive diagnosis of age-related cochlear deafferentation and it may not be necessary to use the CMAP or measure DPOAEs to predict deafferentation in individual patients. Unfortunately, specific recommendations for predicting noise-induced cochlear deafferentation could not be ascertained from this study due to confounding related to OHC dysfunction.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the National Institutes of Health, National Institute on Deafness and Other Communication Disorders - Award #R01DC020423 (to N.F.B). and by resources and facilities at the VA National Center for Rehabilitative Auditory Research (NCRAR) [Center Award #C2361C/I50 RX002361] at the VA Portland Health Care System in Portland, OR.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The IRB of the Veterans Affairs Portland Health Care System (VAPORHCS) gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Financial disclosures/conflicts of interest: This study was funded by the National Institutes of Health, National Institute on Deafness and Other Communication Disorders - Award #R01DC020423 (to N.F.B). and by resources and facilities at the VA National Center for Rehabilitative Auditory Research (NCRAR) [Center Award #C2361C/I50 RX002361] at the VA Portland Health Care System in Portland, OR. There are no conflicts of interest, financial, or otherwise.
Data Availability
All data produced in the present study are available upon reasonable request to the corresponding author.
